Found: 24
Select item for more details and to access through your institution.
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5989, doi. 10.1007/s00432-022-04569-y
- By:
- Publication type:
- Article
Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4591, doi. 10.1007/s00432-022-04367-6
- By:
- Publication type:
- Article
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 4, p. 452, doi. 10.1093/nop/npae026
- By:
- Publication type:
- Article
Hypertrophic lichenoid dermatitis immune‐related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
- Published in:
- Journal of Cutaneous Pathology, 2020, v. 47, n. 10, p. 954, doi. 10.1111/cup.13739
- By:
- Publication type:
- Article
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.
- Published in:
- Journal of Cutaneous Pathology, 2018, v. 45, n. 7, p. 504, doi. 10.1111/cup.13150
- By:
- Publication type:
- Article
Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 1, p. 43, doi. 10.1007/s11912-021-01162-3
- By:
- Publication type:
- Article
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1916, doi. 10.3390/ijms20081916
- By:
- Publication type:
- Article
Interstitial granulomatous dermatitis and concurrent immunotherapy associated encephalitis with nivolumab and ipilimumab.
- Published in:
- Dermatology Online Journal, 2022, v. 28, n. 2, p. 1, doi. 10.5070/D328257399
- By:
- Publication type:
- Article
Ventriculoperitoneal shunting with an on–off valve for patients with leptomeningeal metastases and intracranial hypertension.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 1, p. 56, doi. 10.1093/nop/npad056
- By:
- Publication type:
- Article
Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD).
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.800053
- By:
- Publication type:
- Article
CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.745893
- By:
- Publication type:
- Article
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors.
- Published in:
- Annals of Gastroenterology, 2022, v. 35, n. 4, p. 393, doi. 10.20524/aog.2022.0722
- By:
- Publication type:
- Article
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Molecular insights into melanoma brain metastases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 714, doi. 10.1093/oncolo/oyad039
- By:
- Publication type:
- Article
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1001150
- By:
- Publication type:
- Article
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1781, doi. 10.1093/neuonc/noae103
- By:
- Publication type:
- Article
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 7, p. 1310, doi. 10.1093/neuonc/noac251
- By:
- Publication type:
- Article
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 51, doi. 10.1111/pcmr.13116
- By:
- Publication type:
- Article
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
- Published in:
- Pigment Cell & Melanoma Research, 2022, v. 35, n. 6, p. 554, doi. 10.1111/pcmr.13059
- By:
- Publication type:
- Article
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features.
- Published in:
- Pigment Cell & Melanoma Research, 2022, v. 35, n. 2, p. 229, doi. 10.1111/pcmr.13017
- By:
- Publication type:
- Article
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 975, doi. 10.1002/cncr.34004
- By:
- Publication type:
- Article
Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11443, doi. 10.3390/ijms241411443
- By:
- Publication type:
- Article